fusion-pharmaceuticals
biotech | March 1, 2017
Fusion Pharmaceuticals launches with $25 million to develop cancer treatment
Fusion Pharmaceuticals has launched with $25 million to develop a treatment for cancer. Fusion, based in Ontario, Canada, is developing a targeted deliver of …